Protocadherin Beta 14 (PCDHB14), a member of the cadherin superfamily, is inactivated by aberrant methylation of its promoter in HCC patients and that PCDHB14 ablation inhibit cell cycle arrest, cell proliferation and ferroptosis (Liu Y. et al., 2022). Here, PCDHB14 is linked to hepatocellular carcinoma.